Navigation Links
Implantable monitor may help in managing diastolic heart failure
Date:12/11/2008

Philadelphia, 11 December 2008 An implantable hemodynamic monitor (IHM) may help to guide medical treatment in a large subgroup of patients with heart failurethose with diastolic heart failure (DHF), reports a study in the December Journal of Cardiac Failure (http://www.onlinejcf.com/), published by Elsevier.

Led by Michael R. Zile, M.D., of Medical University of South Carolina, Charleston, the researchers analyzed data on DHF patients enrolled in a larger randomized trial evaluating the IHM for heart failure. The IHM is a surgically implanted device that continuously records data on heart function and other key variables. The data can then be downloaded for analysis by health care professionals, who can use it to make adjustments in medical therapy. The goal is to avoid sudden drops in heart function, called acute decompensation.

The main "COMPASS-HF" study included 274 patients with all types of heart failure. The original results showed that the risk of heart failure events was reduced by about 20 percent in patients treated with the IHM, although the difference was not statistically significant.

The new analysis focused on the subgroup of patients with DHF. In DHF, the heart still has normal pumping function (ejection fraction), but no longer relaxes sufficiently to fill with blood normally. In the COMPASS-HF study, 70 patients with DHF were randomly assigned to receive the IHM, while the rest were managed without the IHM.

As in the main study, DHF patients who received the IHM device had a 20 percent reduction in heart failure events, although the difference was not significant. A 29 percent reduction in the risk of hospitalization for heart failure was also nonsignificant.

The IHM did lead to some significant changes in patient management, including more frequent adjustments in the dose of diureticsa key part of treatment for heart failure. As in the larger study, the IHM device was safe in DHF patients, with a low complication rate.

Patients with chronic heart failure need careful medical management to avoid episodes of acute decompensation. Few studies have focused on patients with DHF, even though they account for about half of all patients with heart failure.

Based on the new analysis, there is as yet no evidence that using the IHM device to guide treatment reduces the risk of decompensation and heart failure events in patients with DHF. The IHM does appear safe for patients with heart failure, with a very low risk of complications. In addition, DHF patients receiving the IHM device show a trend toward lower rates of heart failure events, including hospitalization related to heart failure.

"This is very important study and the trends make sense," comments Barry M. Massie, M.D., Editor-in-Chief of Journal of Cardiac Failure. "Worsening of HF leading to hospitalization, usually as a result of pulmonary congestion and rising blood pressure, is often more abrupt in patients with preserved ejection fraction. Hemodynamic monitoring may provide an early clue and facilitate relatively simple and effective interventions."


'/>"/>

Contact: Maureen Hunter
m.hunter@elsevier.com
215-239-3671
Elsevier
Source:Eurekalert

Related medicine news :

1. Implantable device designed to detect, stop seizures under study at MCG
2. GrantAdler Shipping Novel Implantable Vascular Access Port
3. URGENT Thoratec Corporation Worldwide Recall of Implantable Ventricular Assist Device
4. EaglePicher Technologies Introduces First Implantable Medical Cell Designed Specifically for Monitoring Applications
5. Implantable medical devices may expose patients to security, privacy risks; solutions suggested
6. Northwestern Memorial trials implantable device to manage congestive heart failure symptoms
7. Texcel Introduces Innovative Programmable, Implantable Stimulation System for R&D of Specialty Stimulation Therapies
8. Long-Term Results of VisionCares Implantable Telescope for End-Stage Macular Degeneration Published in the American Journal of Ophthalmology
9. MP3 headphones interfere with implantable defibrillators, pacemakers
10. Signalife to Deploy Fidelity 100 Heart Monitors for AFL
11. System Planning Corporation Launches New Asset Tracking and Monitoring System to Meet Pharmaceutical Industry Needs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/25/2017)... ... ... Refresh Restore Reward”: is a story of struggle and how trouble often happens for ... cofounded the Free Spirit Bible Church and currently serves as the church’s Director of ... to come over before the baby had to go back to her grandparents. In ...
(Date:9/25/2017)... ... 25, 2017 , ... “Grandpa's Visit”: a tender and relatable tale of ... others. “Grandpa's Visit” is the creation of published author, Beverly Brumfield, gifted writer and ... the character in her book. She shares, “Mr. Rice is struggling to keep up ...
(Date:9/25/2017)... ... September 25, 2017 , ... Netmail, Inc . and ... Hadron Data Auditing and eDiscovery services to healthcare organizations as ... Hadron solution in a HIPAA/HITRUST Azure Cloud at the Microsoft Ignite #MSIgnite conference in ...
(Date:9/25/2017)... ... September 25, 2017 , ... Azadian Group, a commercial lender ... downtown Los Angeles, to service existing clients in the Western U.S. and to capitalize ... seeing an ever-increasing amount of business demand west of the Mississippi and we are ...
(Date:9/25/2017)... ... 25, 2017 , ... Emerald Ash Borers kill Ash trees in as little as ... Philadelphia region. A video by Rob Nagy, ISA Certified Arborist at Giroud Tree and ... several are dead or showing signs of decline from Emerald Ash Borers, two Ash trees ...
Breaking Medicine News(10 mins):
(Date:9/23/2017)... , Sept. 22, 2017 Janssen Biotech, Inc. ... response letter from the U.S. Food and Drug Administration ... of sirukumab for the treatment of moderately to severely ... additional clinical data are needed to further evaluate the ... severely active RA. ...
(Date:9/22/2017)... Sept. 22, 2017  As the latest Obamacare repeal ... Bill Cassidy (R-LA) and Lindsey Graham ... the medical device industry is in an odd place. ... the 2.3% excise tax on medical device sales passed ... want covered patients, increased visits and hospital customers with ...
(Date:9/22/2017)... , Sept. 22, 2017 AVACEN Medical ... device is now successfully helping those with the widespread ... Fibromyalgia diagnosed Amanda in Essex, England ... and washing my hair, experiencing no sleep at all, ... painful spasm… I cannot recommend [the AVACEN 100] enough, ...
Breaking Medicine Technology: